CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous form...
Leadership
A. Rachel Leheny Ph.D.
CEO & Director
Eric W. Roberts
Chief Business Officer & Vice Chairman of the Board
